The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUniphar Share News (UPR)

Share Price Information for Uniphar (UPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 221.00
Bid: 218.00
Ask: 224.00
Change: 1.00 (0.45%)
Spread: 6.00 (2.752%)
Open: 221.00
High: 224.00
Low: 221.00
Prev. Close: 220.00
UPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Uniphar gross profit jumps in first half

Thu, 14th Sep 2023 12:27

(Sharecast News) - Healthcare services company Uniphar reported gross profit growth of 28.6% in its first half on Thursday, of which 5.5% was organic, representing progress across all divisions.

The AIM-traded firm said its supply chain and retail segment continued to surpass expectations, with an impressive 7.7% organic growth.

In addition to the gross profit growth, there was a notable rise in the gross profit margin, which increased from 14.7% to 15.2%, while EBITDA jumped 13.8% year-on-year in the six months ended 30 June to €51.1m.

However, adjusted earnings per share saw a marginal decline of one euro cent to 7.4 cents, primarily due to the surge in financing costs.

In terms of acquisitions, Uniphar strengthened its position in the retail pharmacy sector by acquiring the McCauley Pharmacy Group in January, adding considerable value to its service portfolio.

Financially, Uniphar reported a normalised solid free cash flow conversion rate of 68% - a slight decrease from 70% in June last year.

However, there was an increase in net bank debt, which stood at €178m at the end of June, up from €91.2m in December, resulting in a leverage rate of 1.95x.

The board declared an interim dividend of 0.64 euro cents per ordinary share for the first half - 5% higher than the half-year distribution in 2022.

"Just over four years post-IPO, I am pleased to announce that we have already achieved our target of doubling EBITDA within five years," said chief executive officer Ger Rabbette.

"We are now focussed on creating a strong foundation for our next phase of growth, reorganising our divisions to reflect our strategic ambitions and accelerating our progress in our target markets.

"As well as maintaining an active acquisition pipeline, we are also making a significant investment in our IT systems to further enhance the technological backbone of our business and reach our ambitious new target of €200m EBITDA over the medium term."

At 1152 BST, shares in Uniphar were down 3.08% in London, at 220p.

Reporting by Josh White for Sharecast.com.

More News
21 Sep 2020 14:58

UK DIRECTOR DEALINGS SUMMARY: IG Exec Sells Spread Bet On IG Shares

UK DIRECTOR DEALINGS SUMMARY: IG Exec Sells Spread Bet On IG Shares

Read more
18 Sep 2020 14:51

UK EXECUTIVE CHANGE SUMMARY: New CEOs At SpaceandPeople And Quarto

UK EXECUTIVE CHANGE SUMMARY: New CEOs At SpaceandPeople And Quarto

Read more
2 Sep 2020 10:43

UK WINNERS & LOSERS SUMMARY: Computacenter Surges On Positive Outlook

UK WINNERS & LOSERS SUMMARY: Computacenter Surges On Positive Outlook

Read more
2 Sep 2020 09:59

Uniphar Unveils Acquisitions Amid Surge In Interim Earnings

Uniphar Unveils Acquisitions Amid Surge In Interim Earnings

Read more
2 Sep 2020 08:43

Uniphar ends first half in line with forecasts

(Sharecast News) - Healthcare services business Uniphar reported interim results in line with expectations on Wednesday, with revenue rising 8.8% year-on-year to €871.33m (£775.71m).

Read more
26 Aug 2020 15:57

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
28 Jul 2020 15:36

IN BRIEF: Uniphar Says Virus Brings Both Challenge And Opportunity

IN BRIEF: Uniphar Says Virus Brings Both Challenge And Opportunity

Read more
28 Jul 2020 09:41

Uniphar ends first half in line with expectations

(Sharecast News) - Healthcare services company Uniphar updated the market on its first half on Tuesday, saying it had performed in line with expectations for the six months through June at both a gross profit and EBITDA level.

Read more
30 Jun 2020 18:24

UK EXECUTIVE CHANGE SUMMARY: Stobart Adds Former Luton Airport Head

UK EXECUTIVE CHANGE SUMMARY: Stobart Adds Former Luton Airport Head

Read more
26 May 2020 14:14

UK TRADING UPDATE SUMMARY: Yourgene To Enter Covid-19 Testing Space

UK TRADING UPDATE SUMMARY: Yourgene To Enter Covid-19 Testing Space

Read more
19 May 2020 15:56

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
21 Apr 2020 16:08

UK EXECUTIVE CHANGE SUMMARY: Carnival Adds Walmart Veteran To Board

UK EXECUTIVE CHANGE SUMMARY: Carnival Adds Walmart Veteran To Board

Read more
27 Mar 2020 14:48

Uniphar Revenue Surges In 2019 But Covid-19 Could Hurt 2020 Earnings

Uniphar Revenue Surges In 2019 But Covid-19 Could Hurt 2020 Earnings

Read more
23 Mar 2020 15:03

Uniphar Sees Spike In Demand In Past 20 Days, Expects Continued Rise

Uniphar Sees Spike In Demand In Past 20 Days, Expects Continued Rise

Read more
4 Feb 2020 13:14

Uniphar ends 2019 in line with expectations

(Sharecast News) - Pharmaceutical and medical technology services company Uniphar updated the market on its trading in 2019 on Tuesday, reporting that it performed in line with its own expectations for the full year at both a gross profit and EBITDA level.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.